Trial phases of COVID-19 vaccines developed by Melbourne researchers given cash boost

Original article by Alanah Frost
Herald Sun – Page: Online : 3-Jan-21

The federal government has announced $10.1 million in funding for six clinical trials relating to COVID-19 vaccines, including two vaccines that are being developed by Melbourne researchers. Teams at the Peter Doherty Institute for Infection and Immunity are among those involved in the development of the two vaccines, which can be readily modified to combat COVID-19 mutations. Phase 1 clinical trials of the vaccines are due to begin in mid-2021, while the federal government will maintain its plans to roll out the Pfizer vaccine in March

CORPORATES
UNIVERSITY OF MELBOURNE. PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY